Central Nervous System
For any information related to the publications listed below, please do not hesitate to contact the FORENAP group
2007
Boeijinga PH, Soufflet L, Santoro F, Luthringer R.Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man. J Psychopharmacol 2007;21(3):321-337.
Deacon S, Staner L, Staner C, Legters A, Loft H, Lundahl J.
Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia. Sleep 2007;30(3):281-287.
Dunbar G, Boeijinga PH, Demazières A, Cisterni C, Kuchibhatla R, Wesnes K, Luthringer R.
Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers. Psychopharmacology 2007;191(4):919-929.
Gilles C, Luthringer R.
Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs. J Psychopharmacol 2007;21(3):272-282.
Lundahl J, Staner L, Staner C, Loft H, Deacon S.
Short treatment with Gaboxadol improves sleep maintenace and enhances slow wave sleep in adult patients with primary insomnia. Psychopharmacology 2007 Jul 27; [Epub ahead of print].
Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, Cleton A, Eerdekens M, Battisti WP, Palumbo JM.
A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol 2007 ; 22(5):299-308.
Morain P, Boeijinga P, Demazières A, De Nanteuil G, Luthringer R.
Psychotropic profile of S 17092, a prolyl-endopeptidase inhibitor, using quantitative EEG in young healthy volunteers. Neuropsychobiology 2007;55:176-183.
Muzet A.
Environmental noise, sleep and health. Sleep Medicine Reviews 2007;11:135-142.
2006
Aubin HJ, Luthringer R, Demazières A, Dupont C, Lagrue G.
Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep. Nic Tob Res 2006; 8(2):193-201.
Cerf R
Catastrophe Theory enables moves to be detected towards and away from self-organization: the example of epileptic seizure onset. Biol Cybernetics 2006; 94(6):459-68
Demazieres A, Luthringer R, Coppel E, Gilles C, Fleury C, Roegel JC, Delarue A, Laur C, Lagrue G
Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers. Addict Behav 2006, 31(3):537-43.
Dunbar G, Demazières A, Monreal A, Cisterni C, Metzger D, Kuchibhatla R, Luthringer R.
Pharmacokinetics and safety profile of ispronicline (TC-1734), a new brain nicotinic receptor partial agonist, in young healthy male volunteers. J Clin Pharmacol 2006;46(7):715-726
Muzet A.
Vigilance et sécurité.In: Bimes-Arbus S, Lazorthes Y, Rougé D et al. Sciences Humaines et Sociales, Abrégés PCEM1, Paris, Masson, 2006. 447-452.
Muzet A..
Bruit et sommeil: répercussions sur la santé. Medecine/Sciences, 2006;22: 973-977.
Pitchot W, Zouery D, Staner L, Zdanowicz N, Floris M.
Système dopaminergique, dépression et antidépresseur. Acta Psychiatrica Belgica 2006, 106:5-13.
Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y, Demazieres A, Luthringer R
Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety. Neuroimage 2006. 31(3):1197-208
Staner L, Luthringer R, Dupont C, Aubin HJ, Lagrue G.
Sleep effects of a 24-hour versus a 16-hour nicotine patch: a polysomnographic study during smoking cessation. Sleep med 2006, 7:147-54.
Staner L.
Surrogate outcomes in neurology, psychiatry, and psychopharmacology. Dialogues in Neurosciences 2006;8(3):345-352.
2005
Chalon S, Pereira A, Lainey E et al. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. Psychopharmacology (Berl) 2005; 177(4):357-65.
Haba-Rubio J, Staner L, Krieger J, Macher JP. Periodic limb movements and sleepiness in obstructive sleep apnea patients. Sleep Med 2005; 6(3):225-9.
Haba-Rubio J, Staner L, Petiau C, Erb G, Schunck T, Macher JP. Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry 2005; 76(7):1009-10.
Hode Y, Reimold M, Demazières A et al. A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian). Psychopharmacology 2005; 180(2):377-84.
Le Bon O, Chabanski S, Dramaix M, Staner L, Pelc I, Linkowski P. Inverse association between Slow Wave Activity per cycle and the number of ultradian sleep cycles per night in healthy humans. Clin Neurophysiol 2005; 116(7):1493-500.
Peter JC, Tugler J, Eftekhari P, Maurice D, Hoebeke J, Roegel JC. Effects on heart rate of an anti-M2 acetylcholine receptor immune response in mice. FASEB J 2005; 19(8):943-9.
Soufflet L, Boeijinga PH. Linear inverse solutions: simulations from a realistic head model in MEG. Brain Topogr 2005; 18(2):87-99.
Staner L, Ertle S, Boeijinga P et al. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacology (Berl) 2005; 181(4):790-8.
Tremeau F, Malaspina D, Duval F et al. Facial expressiveness in patients with schizophrenia compared to depressed patients and nonpatients comparison subjects. Am J Psychiatry 2005; 162(1):92-101.
2004
Boeijinga PH, Parot P, Soufflet L et al. Pharmacodynamic effects of Acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence. Neuropsychobiology 2004; 50(1):71-7.
Bolo NR, Hode Y, Macher JP. Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo. MAGMA 2004; 16:268-76.
Cerf R, Ouasdad el HE, Kahane P. Criticality and synchrony of fluctuations in rhythmical brain activity: pretransitional effects in epileptic patients. Biol Cybern 2004; 90(4):239-55.
Duval F, Crocq MA, Guillon MS et al. Increased adrenocorticotropin suppression following dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Psychoneuroendocrinology 2004; 29(10):1281-9.
Duval F, Crocq MA, Guillon MS et al. Increased adrenocorticotropin suppression following dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Ann N Y Acad Sci 2004; 1032:273-5.
Haba-Rubio J, Staner L, Krieger J, Macher JP. What is the clinical significance of periodic limb movements during sleep? Neurophysiol Clin 2004 Dec;34(6):293-300.
Jonsson EG, Kaiser R, Brockmoller J, Nimgaonkar VL, Crocq MA. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatr Genet 2004; 14(1):9-12.
Peter JC, Wallukat G, Tugler J et al. Modulation of the M2 muscarinic acetylcholine receptor activity with monoclonal anti-M2 receptor antibody fragments. J Biol Chem 2004; 279(53):55697-706.
2003
Boeijinga PH, Nedelec JF, Demazieres A et al . Characterization of the CNS Effects of Naftidrofuryl (Praxilene(R)) by Quantitative EEG and Functional MRI: A Study in Healthy Elderly Subjects. Neuropsychobiology 2003; 48(3):160-8.
Crevoisier C, Monreal A, Metzger B, Nilsen T. Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy volunteers. Eur Neurol 2003; 49(1):39-44.
Dimicoli JL, Patry J, Blouquit Y, Nedelec JF, Adam R. Multinuclear NMR investigations on the metabolic recovery of the isolated perfused mouse liver after cold preservation. Biochimie 2003; 85(9):891-903.
Duval F, Mokrani MC, Monreal J et al. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests. Psychoneuroendocrinology 2003; 28(5):627-42.
Jonsson EG, Burgert E, Crocq MA et al. Association study between dopamine D3 receptor gene variant and personality traits. Am J Med Genet 2003; 117B(1):61-5.
Jonsson EG, Flyckt L, Burgert E et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr Genet 2003; 13(1):1-12.
Le Bon O, Murphy JR, Staner L et al. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol 2003; 23(4):377-8.
Staner L, Cornette F, Maurice D et al. Sleep microstructure around sleep onset differentiates major depressive insomnia from primary insomnia. J Sleep Res 2003; 12(4):319-30.
Staner L, Duval F, Haba J, Mokrani MC, Macher JP. Disturbances in hypothalamo pituitary adrenal and thyroid axis identify different sleep EEG patterns in major depressed patients. J Psychiatr Res 2003; 37(1):1-8.
2002
Correa H, Duval F, Mokrani MC et al. Serotonergic function and suicidal behavior in schizophrenia. Schizophr Res 2002; 56(1-2):75-85.
Haba-Rubio J, Staner L, Macher JP. Periodic arousals or periodic limb movements during sleep ? Sleep Medicine 2002; 3(6):517-20.
Le Bon O, Staner L, Rivelli SK, Hoffmann G, Pelc I, Linkowski P. Correlations using the NREM-REM sleep cycle frequency support distinct regulation mechanisms for REM and NREM sleep. J Appl Physiol 2002; 93(1):141-6.
Llorca PM, Spadone C, Sol O et al. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study. J Clin Psychiatry 2002; 63(11):1020-7.
Massat I, Souery D, Del-Favero J et al. Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European multicenter association study of affective disorders. Am J of Med Genet 2002; 114(2):177-85.
Staner L, Uyanik G, Correa H et al. A dimensional impulsive-aggressive phenotype is associated with the A218C polymorphism of the tryptophan hydroxylase gene: a pilot study in well-characterized impulsive inpatients. Am J Med Genet 2002; 114(5):553-7.
Viola AU, Brandenberger G, Toussaint M, Bouhours P, Macher J-P, Luthringer R. Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers. Clin Neurophysiol 2002; 113(3):429-34.
